The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Hydrogenics Corp

Nasdaq: HYGS
Last

(U.S.) $7.87

Today's change-0.10 -1.25%
Updated February 10 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Hydrogenics Corp

Nasdaq: HYGS
Last

(U.S.) $7.87

Today's change-0.10 -1.25%
Updated February 10 4:00 PM -5GMT. Delayed by at least 15 minutes.

Hydrogenics Corp down (U.S.)$0.10

Hydrogenics Corp closed lower Wednesday, dropping (U.S.)$0.10 or 1.25% to (U.S.)$7.87. Although unchanged over the last five days, shares are down 10.26% for the last year to date. This security has underperformed the S&P 500 by 34.68% during the last year.

Key company metrics

  • Open(U.S.) $7.97
  • Previous close(U.S.) $7.97
  • High(U.S.) $8.01
  • Low(U.S.) $7.62
  • Bid / Ask(U.S.) $6.49 / (U.S.) $9.20
  • YTD % change-10.26%
  • Volume26,314
  • Average volume (10-day)64,997
  • Average volume (1-month)84,912
  • Average volume (3-month)78,186
  • 52-week range(U.S.) $5.41 to (U.S.) $17.55
  • Beta0.63
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.86
Updated February 10 4:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-21.65%

Hydrogenics Corp has a net profit margin of -21.65%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.79%Sector:Industry:

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue107816
Total other revenue--------
Total revenue107816
Gross profit2113
Total cost of revenue86613
Total operating expense11101015
Selling / general / administrative3332
Research & development1110
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-2-3-20
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-4-31
Income after tax-2-4-31
Income tax, total0000
Net income-2-4-31
Total adjustments to net income--------
Net income before extra. items-2-4-31
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-4-31
Inc. avail. to common incl. extra. items-2-4-31
Diluted net income-2-4-31
Dilution adjustment--------
Diluted weighted average shares10101010
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.37-0.340.06
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.22-0.37-0.340.06